title: Postpartum hyperkalemia associated with magnesium sulfate.
abstract: We report the case of a woman who first received MgSO(4) for eclampsia prophylaxis and then was treated with MgSO(4) for eclampsia. She developed hyperkalemia without severe renal failure or another explanation. We recommend close monitoring, including serial measurements of electrolytes, when MgSO(4) is administered for eclampsia prophylaxis or treatment.
authors.affiliation: Maternal/Fetal Medicine, Department of Obstetrics and Gynaecology, British Columbia Women's Hospital and Health Centre, Vancouver, British Columbia, Canada. iglesiasmh@gmail.com
authors.forename: Marie-Hélène
authors.initials: MH
authors.lastname: Iglesias
authors.forename: Ellen M
authors.initials: EM
authors.lastname: Giesbrecht
authors.forename: Peter
authors.initials: P
authors.lastname: von Dadelszen
authors.forename: Laura A
authors.initials: LA
authors.lastname: Magee
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D004461:Eclampsia / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D008278:Magnesium Sulfate / Q000009:adverse effects*; D049590:Postpartum Period; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D011644:Puerperal Disorders / Q000139:chemically induced*; D051437:Renal Insufficiency / Q000139:chemically induced*
chemical_list: D000927:Anticonvulsants; D008278:Magnesium Sulfate